MolecularMD Lands $6,000,000 Series B Funding Round

  • Feed Type
  • Date
    4/2/2012
  • Company Name
    MolecularMD
  • Mailing Address
    1341 SW. Custer Dr. Portland, OR 97219
  • Company Description
    Founded in 2006, MolecularMD is a molecular diagnostics company specializing in clinical development and commercialization of state-of-the-art genomic assays to measure patient response and resistance to targeted cancer therapies. The company has over 30 years of combined experience in cancer research and has developed sensitive and highly reliable molecular assays for leukemias, lymphomas, and solid tumors.
  • Website
    http://www.molecularmd.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from the Series B investment will accelerate the commercial launch of new platforms and related assay content in such areas such as next generation sequencing and rare mutant detection. Investment proceeds will also be applied to the expansion of sales and marketing activities to support near term growth objectives.
  • M&A Terms
  • Venture Investor
    Ballast Point Ventures
  • Venture Investor
    Nextech Invest

By posting a comment, you agree to our terms and conditions.